STE — STERIS plc (Ireland) stock price and chart

STE

$247.91+7.16%

as of close, Nov 4, 2026

☾ AH $247.91 +7.16%

STERIS plc (Ireland)Stock · HealthcareS&P 500 Equal Weight · 0.2% of RSPS&P 500 · 0.03% of SPYRussell 1000 · 0.03% of IWBUS Stock Market · 0.03% of VTIRussell 3000 · 0.03% of IWVMSCI World · 0.03% of URTHMSCI ACWI · 0.02% of ACWI

PeersEWZBHSNNGEHCPHGDXCM

Share this page

Head-to-head:Compare with EW or any ticker →

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEEDEDEDE

20162019202120242026

80.0100.0120.0140.0160.0180.0200.0220.0240.0260.0010.0M$247.91

2026-11-04

Price$247.91

MA20$220.54

MA50$233.38

Vol3.7M

What would $1,000 invested in STE be worth today? →

STE returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $247.91
YTD price return: -2.21%
YTD total return: -1.37%
Market cap: 24.2B2017-03 6B2026-11 24.2B+304.7% over the window
Enterprise value: 25.8B
Shares outstanding: 97.5M2017-03 86.1M2026-06 97.5M+13.2% over the window
52W low: $195.14
52W high: $269.44
From 52W high: -7.99%
From 52W low: +27.04%
52W range: 71%$195–$269
Beta: 0.91

Volume

Rel volume: 1.99×
30D volume: 691.8K
30D $ vol: 153.5M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1MNo open-market insider purchase or sale with a transaction date in the last 30 days, as filed on Form 4.: none
Insider net 3M0 insider-days of buying (no priced lot) and 1 of selling ($957K) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$957K
Insider net 1Y0 insider-days of buying (no priced lot) and 6 of selling ($3.2M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$3.2M

Form 4 transactions by trade date, as filed; latest on file 2026-08-12.

Fundamentals

Sales (ttm): 6B2017-03 2.6B2026-06 6B+131.1% over the window
Sales/share: $61.922017-03 $30.352026-06 $61.92+104.0% over the window
EPS (ttm): $8.182017-03 $1.282026-06 $8.18+539.0% over the window
FCF (ttm): 925.6M2017-03 251.2M2026-06 925.6M+268.5% over the window
FCF/share: $9.492017-03 $2.922026-06 $9.49+225.4% over the window
Book value/share: $73.912018-03 $37.832026-06 $73.91+95.4% over the window
Net margin: 13.33%2017-03 4.2%2026-06 13.3%+216.8% over the window
ROE: 11.17%2018-03 9.1%2026-06 11.2%+23.1% over the window
ROA: 7.50%2018-03 5.6%2026-06 7.5%+34.1% over the window
Debt / equity: 0.23×2018-03 0.412026-06 0.23-44.2% over the window
Current ratio: 1.912018-03 2.482026-06 1.91-23.3% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.38%2025-06-30 → 2026-06-305.6B → 6B (+8.4% total)+8.95%2023-06-30 → 2026-06-304.7B → 6B (+29.3% total)+12.13%2021-06-30 → 2026-06-303.4B → 6B (+77.2% total)n/a
Net income: +24.55%2025-06-30 → 2026-06-30646.5M → 805.1M (+24.5% total)+88.94%2023-06-30 → 2026-06-30119.3M → 805.1M (+574.7% total)+23.00%2021-06-30 → 2026-06-30286M → 805.1M (+181.5% total)n/a
FCF: +1.85%2025-06-30 → 2026-06-30908.8M → 925.6M (+1.8% total)+23.30%2023-06-30 → 2026-06-30493.7M → 925.6M (+87.5% total)+16.89%2021-06-30 → 2026-06-30424.1M → 925.6M (+118.2% total)n/a
Shares: -1.01%2025-06-30 → 2026-06-3098.5M → 97.5M (-1.0% total)-0.43%2023-06-30 → 2026-06-3098.8M → 97.5M (-1.3% total)-0.46%2021-06-30 → 2026-06-3099.8M → 97.5M (-2.3% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS: +25.18%2025-06-30 → 2026-06-30$6.54 → $8.18 (+25.2% total)+88.54%2023-06-30 → 2026-06-30$1.22 → $8.18 (+570.5% total)+19.62%2021-06-30 → 2026-06-30$3.34 → $8.18 (+144.9% total)n/a
Sales/share: +9.48%2025-06-30 → 2026-06-30$56.56 → $61.92 (+9.5% total)+9.43%2023-06-30 → 2026-06-30$47.26 → $61.92 (+31.0% total)+12.64%2021-06-30 → 2026-06-30$34.15 → $61.92 (+81.3% total)n/a
FCF/share: +2.89%2025-06-30 → 2026-06-30$9.23 → $9.49 (+2.9% total)+23.84%2023-06-30 → 2026-06-30$5.00 → $9.49 (+89.9% total)+17.43%2021-06-30 → 2026-06-30$4.25 → $9.49 (+123.3% total)n/a
Book value/share: +4.64%2025-06-30 → 2026-06-30$70.64 → $73.91 (+4.6% total)+5.78%2023-06-30 → 2026-06-30$62.44 → $73.91 (+18.4% total)+2.32%2021-06-30 → 2026-06-30$65.90 → $73.91 (+12.2% total)n/a
Dividend/share: +10.53%2025-06-30 → 2026-06-30$2.28 → $2.52 (+10.5% total)+10.26%2023-06-30 → 2026-06-30$1.88 → $2.52 (+34.0% total)+9.51%2021-06-30 → 2026-06-30$1.60 → $2.52 (+57.5% total)n/a
Price: +2.51%2025-11-04 → 2026-11-04$241.85 → $247.91 (+2.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+4.50%2023-11-03 → 2026-11-04$217.23 → $247.91 (+14.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+2.21%2021-11-04 → 2026-11-04$222.24 → $247.91 (+11.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+14.43%2016-11-03 → 2026-11-04$64.40 → $247.91 (+285.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +3.39%2025-11-04 → 2026-11-04$239.79 → $247.91 (+3.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+5.48%2023-11-03 → 2026-11-04$211.18 → $247.91 (+17.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+3.16%2021-11-04 → 2026-11-04$212.21 → $247.91 (+16.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+15.61%2016-11-03 → 2026-11-04$58.10 → $247.91 (+326.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 30.3×2017-03 54.382026-11 30.06-44.7% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 21.2×2017-03 26.442026-11 21.20-19.8% over the window
Fwd P/E: 19.6×
P/S (ttm)Market cap ÷ TTM revenue.: 4.0×2017-03 2.292026-11 4.01+75.1% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.4×2018-06 2.782026-11 3.36+21.0% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 26.1×2017-03 23.812026-11 26.15+9.8% over the window
EV/EBITDA (fy): 15.8×
EV/Sales (ttm): 4.3×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.83%2017-03 4.2%2026-06 4.5%+7.7% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.Div yieldIndicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 1.11%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $2.76
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 97.5M ÷ 98.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 1.01%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (1.01%) + dividends paid over that year ($247M) ÷ market_cap_at(2025-06-30) ($23.7B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 2.05%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($340.4M) ÷ today's market cap ($24.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 1.41%2017-03 1.6%2026-06 1.7%+2.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $340.4M + TTM dividends $247M) ÷ today's market cap ($24.2B). Same caveat as the cash buyback yield.: 2.43%2017-03 3.2%2026-06 2.9%-10.0% over the window

Vs own 10Y history

P/E: 12th
P/OI: 11th
P/S: 29th
P/B: 38th
P/FCF: 14th

Bar = where today’s multiple sits in STE’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-04#

+7.16%

+8.36%

+18.88%

+6.47%

YTD

-2.21%

+2.51%

+11.55%

+7.16%

+8.36%

+18.88%

+6.79%

YTD

-1.37%

+3.39%

+16.82%

Fundamentals#

Revenue

5Y CAGR +13.8%5Y CAGR +13.8%YoY +7.3%

$6B TTM$1.5B Q1 '27

FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM

Q1 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Operating income

5Y CAGR +15.0%5Y CAGR +15.0%YoY +16.2%

$1.1B TTM$285.8M Q1 '27

FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM

Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

EPS (diluted)

5Y CAGR +11.4%5Y CAGR +11.4%YoY +14.0%

$8.18 TTM$2.04 Q1 '27

FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM

Free cash flow

5Y CAGR +16.6%5Y CAGR +16.6%YoY −14.3%

$925.6M TTM$279.6M Q1 '27

FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM

TTM: operating cash flow $1.3B, capex −$362.9M

Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Q1 2027: operating cash flow $367.1M, capex −$87.5M

Shares (diluted)

5Y +14.9%5Y +14.9%YoY −0.9%

98.4M TTM97.9M Q1 '27

FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM

Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Dividend per share

5Y CAGR +9.4%5Y CAGR +9.4%YoY +10.5%

$2.52 TTM$0.63 Q1 '27

FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM

Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Full STE financials →

About STERIS plc (Ireland)#

STERIS plc is a healthcare and life sciences company that provides infection prevention, contamination control, and procedural products and services. The company offers a broad portfolio that includes sterilizers, surgical tables, endoscopy accessories, cleaning chemistries, instrument and scope repair, laboratory testing, and outsourced reprocessing services. Its operations support hospitals, ambulatory surgery centers, pharmaceutical and medical device manufacturers, and research laboratories. STERIS plc also serves biopharmaceutical and life sciences customers with contamination-control equipment, sterilization technologies, and related maintenance services. Through its mix of consumables, capital equipment, and recurring service offerings, the company plays an important role in helping healthcare and production environments maintain sterile conditions and support patient care across global markets.

Mentor, OH·17,937 employees·Medical Devices·steris.com·As of Oct 28, 2026

Recent filings#

Nov 4Earnings · Earnings release — EPS $2.47 vs $2.67 est.
Aug 12Insider sale · Sohi Mohsen (Director) sold 4,058 shares for $957K at $235.78
Aug 5Earnings · Earnings release — EPS $2.59 vs $2.54 est. (+2.0%); revenue $1.49B (+7% y/y) 0.4%

All filings and insider trades →

ETFs holding STE#

35 of the 193 ETFs ChartRow carries live hold STE. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

Fund	Name	Filed weight
XLV	Health Care Select Sector SPDR Fund	0.4%
VHT	Vanguard Health Care ETF	0.3%
VOT	Vanguard Mid-Cap Growth ETF	0.2%
RSP	Invesco S&P 500 Equal Weight ETF	0.2%
IWS	iShares Russell Mid-Cap Value ETF	0.2%
VO	Vanguard Mid-Cap ETF	0.2%
VOE	Vanguard Mid-Cap Value ETF	0.2%
IWR	iShares Russell Midcap ETF	0.1%

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+24.07%	+0.61%
JNJ	Johnson & Johnson	+7.92%	+3.81%
ABBV	AbbVie Inc.	+12.18%	+3.09%
MRK	Merck & Co. Inc.	+4.20%	+3.93%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+10.08%	+1.22%
NVS	Novartis AG	+17.01%	+3.59%
TMO	Thermo Fisher Scientific Inc.	+7.84%	+1.12%
AMGN	Amgen Inc.	+18.69%	+3.71%

Head-to-head:Compare with EW or any ticker →

STE — STERIS plc (Ireland) price, chart and key statistics

Key stats#

Price data

Volume

Insider trading

Fundamentals

Growth (CAGR, ttm) · 10Y

Per-share growth (CAGR, ttm) · 10Y

Valuation

Vs own 10Y history

Performance · price returntotal return · as of 2026-11-04#

Fundamentals#

Revenue

Operating income

EPS (diluted)

Free cash flow

Shares (diluted)

Dividend per share

About STERIS plc (Ireland)#

Recent filings#

ETFs holding STE#

Related Healthcare#